For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240515:nRSO4356Oa&default-theme=true
RNS Number : 4356O Iofina PLC 15 May 2024
15 May 2024
Iofina plc
("Iofina", the "Company" or the "Group")
(AIM: IOF)
Notice of AGM, Resignation of Director and Investor Webinar
Iofina plc, specialists in the exploration and production of iodine and
manufacturers of specialty chemical products, today announces that its 2024
Annual General Meeting ('AGM') will take place on 13 June 2024 at 10:00 a.m.
at the offices of Canaccord Genuity, 88 Wood Street, London EC2V 7QR. The
Notice of AGM is being posted to shareholders and a copy of the Notice will be
made available on the Company's website.
Dr. William ("Bill") D. Bellamy, Chair of the Remuneration Committee, will
retire as a Director of the Company at the close of the AGM and is therefore
not being submitted for re-appointment in the business of the meeting.
Commenting on Dr. Bellamy retiring from the Board, Dr. Tom Becker, CEO and
President said: "On behalf of everyone, I would like to thank Bill for his
services to Iofina over the last ten years. His expertise and practical
experience have played an important role in Iofina's evolution in becoming a
significantly stronger Company. We wish him well in his future endeavours and
travels."
Investor Webinar
Iofina will hold a live investor session via the Investor Meet Company
platform on Wednesday 22 May 2024 at 1:00pm BST. The session will discuss the
recent FY23 results along with the Company's forthcoming corporate strategy.
The presentation is open to all existing and potential investors. Questions
can be submitted pre-event via your Investor Meet Company dashboard up until
9:00 am the day before the meeting or at any time during the live
presentation.
Investors can sign up to Investor Meet Company for free and add to
meet Iofina via:
https://www.investormeetcompany.com/iofina-plc/register-investor
(https://www.investormeetcompany.com/iofina-plc/register-investor) . Those
investors who already follow Iofina on the Investor Meet Company platform will
automatically be invited.
Enquiries:
Dr. Tom Becker
CEO & President
Iofina plc
Tel: +44 (0)20 3006 3135
Nomad & Broker:
Henry Fitzgerald-O'Connor/Harry Rees
Canaccord Genuity Limited
Tel: +44 (0)20 7523 8000
Media Contact:
Charles Goodwin/Shivantha Thambirajah/Zara McKinlay
Yellow Jersey PR Limited
Tel: +44 (0)7747 788 221/+44 (0)7983 521 488
About Iofina:
Iofina plc (AIM: IOF) is a vertically integrated company that specialises in
the production of Iodine and the manufacturing of specialty chemical products.
Iofina is the second largest producer of iodine in North America and operates
the manufacturing entities Iofina Resources and Iofina Chemical.
LEI: 213800QDMFYVRJYYTQ84
ISIN: GB00B2QL5C79
Iofina Resources
Iofina Resources develops, builds, owns, and operates iodine extraction plants
using Iofina's WET® IOsorb® technology. Iofina currently operates six
producing IOsorb® plants in Oklahoma and is consistently using technology and
innovation to improve and expand its operations.
Iofina Chemical
Iofina Chemical has manufactured high quality halogen speciality chemicals
derived from raw iodine, as well as non-iodine-based products. Iofina Chemical
celebrated its 40(th) anniversary in 2023 as a preeminent halogen-based
specialty chemicals company.
www.iofina.com (http://www.iofina.com)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END NOAUSVNRSOUVAAR